跳至主要内容
临床试验/IRCT20210405050849N1
IRCT20210405050849N1尚未招募2 期

Effects of Adding Azithromycin to Standard Outpatient and Inpatient COPD Treatment in Shahrekord University of Medical Sciences Hospitals

Shahre-kord University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 70 years(—)
性别
All

入选标准

  • Diagnosis of COPD by an internal medicine physician, based on the classification of global pioneers of chronic obstructive pulmonary disease (GOLD)
  • No other chronic diseases such as orthopedic and motor diseases, multiple sclerosis or cancer.
  • hospitalization
  • stability of the patient's physical and mental condition

排除标准

  • Lack of motivation of the patient to cooperation
  • Immune system defects (recurrent respiratory infections and worsening of shortness of breath)
  • Existence of concomitant asthma
  • Complications of azithromycin
  • non-pulmonary diseases like cancer; liver dysfunction, cholestatic jaundice,
  • Infiltration and consolidation in chest x-ray
  • Patients with acute exacerbation of COPD
  • Existence of atopy or allergic rhinitis
  • Kidney failure
  • hearing loss

研究者

发起方
Shahre-kord University of Medical Sciences

相似试验